H-ras and K-ras gene mutations in primary human soft tissue sarcoma: Concomitant mutations of the ras genes

Modern Pathology

Volumn 12, Issue 8, 1999, Pages 775-780

  Yoo, Jinyoung ^b   Robinson, Robert A ^a,c   Lee, Jung Yong ^b  

^a UNIVERSITY OF IOWA   (United States)

^b The Catholic University of Korea   (South Korea)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Mutation; Oncogene; Ras; Sarcoma; Sequencing

Indexed keywords

ASPARTIC ACID; DNA; GLYCINE; VALINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOFIBROMA; DNA SEQUENCE; FEMALE; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEIOMYOSARCOMA; LIPOSARCOMA; MALE; ONCOGENE H RAS; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SEQUENCE ANALYSIS; SOFT TISSUE SARCOMA;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENES, RAS; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; SARCOMA;

EID: 0032819299     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gill S, Stratton MR, Patterson H, Spurr NK, Fisher C, Gusterson BA, et al. Detection of transforming genes by transfection of DNA from primary soft-tissue tumors. Oncogene 1991;6:1651-6.
2. Yoo J, Lee HK, Kang CS, Park WS, Lee JY, Shim SI. p53 gene mutations and p53 protein expression in human soft tissue sarcomas. Arch Pathol Lab Med 1997;121:395-9.
3. Wilke W, Maillet M, Robinson R. H-ras-1 point mutations in soft tissue sarcomas. Mod Pathol 1993;6:129-32.
4. Cooper CS, Stratton MR. Soft tissue tumors: the genetic basis of development. Carcinogenesis 1991;12:155-65.
5. Enzinger FM, Weiss SW, editors. Soft tissue tumors. 3rd ed. St. Louis, MO: Mosby; 1988.
6. Andreassen A, Oyjord T, Hovig E, Holm R, Florenes VA, Nesland JM, et al. p53 abnormalities in different subtypes of human sarcomas. Cancer Res 1993;53:468-71.
7. Wadayama B, Toguchida J, Yamaguchi T. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 1993;68:1134-9.
8. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 1992;52: 6194-9.
9. Stratton MR, Moss S, Warren W, Patterson H, Clark J, Fisher C, et al. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene 1990;5:1297-301.
10. Leach FS, Tokino T, Meltzer P. p53 mutation and mdm2 amplification in human soft tissue sarcomas. Cancer Res 1993;52:2231-4.
11. Bos JL. The ras gene family and human carcinogenesis. Mutat Res 1988;195:255-71.
12. Barbacid M. ras genes. Annu Rev Biochem 1987;56:779-827.
13. Siegfried JM, Gillespie AT, Mera R, Casey TJ, Keohavong P, Testa JR, et al. Prognostic value of specific K-ras mutations in lung adenocarcinomas. Cancer Epidemiol Biomarkers Prev 1997;6:841-7.
14. Keohavong P, Zhu D, Melacrinos AC, Demichele MAA, Weyant RJ, Luketich JD, et al. Detection of low-fraction K-ras mutations in primary lung tumors using a sensitive method. Int J Cancer 1997;74:162-70.
15. Motojima K, Furui J, Kohara N, Izawa K, Kanemats HT, Shiku H. Expression of Kirsten-ras-p21 in gastric cancer correlates with tumor progression and is prognostic. Diagn Mol Pathol 1994;3:184-91.
16. Span M, Moerkerk PT, de Goeij AF, Arenas JW. A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients. Int J Cancer 1996;69:241-5.
17. Cerottini JP, Caplin S, Saraga E, Givel JC, Benhattar J. The type of K-ras mutation determines prognosis in colorectal cancer. Am J Surg 1998;175:198-202.
18. Robinson RA. K-ras mutations and the diagnosis of pancreatic carcinoma. Am J Clin Pathol 1996;105:257-9.
19. Apple SK, Hecht JR, Novak JM. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears. Am J Clin Pathol 1996;105: 321-6.
20. Tada M, Omata M, Ohto M. Clinical application of ras gene mutations for diagnosis of pancreatic adenocarcinoma. Gastroenterology 1991;100:233-8.
21. Grunewald K, Lyons J, Frohlich A, Feichtinger H, Weger RA, Schwab G, et al. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989;43: 1037-41.
22. Tada M, Yokosuka O, Omata M, Ohto M, Isono K. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990; 66:930-5.
23. Stratton MR, Fisher C, Gusterson BA, Cooper CS. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res 1989; 49:6324-7.
24. Antillon-Klussmann F, Garcia-Delgado M, Villa-Elizaga I, Sierrasesumaga L. Mutational activation of ras genes is absent in pediatric osteosarcoma. Cancer Genet Cytogenet 1995;79: 49-53.
25. Hill MA, Gong C, Casey TJ, Menen AG, Mera R, Gillespie AT, et al. Detection of K-ras mutations in resected primary leiomyosarcoma. Cancer Epidemiol Biomarkers Prev 1997;6: 1095-100.
26. Hall KL, Teneriello MG, Taylor RR, Lemon S, Ebina M, Linnoila RI, et al. Analysis of Ki-ras, p53, and mdm2 genes in uterine leiomyomas and leiomyosarcomas. Gynecol Oncol 1997;65:330-5.
27. Bohle RM, Brettreich S, Repp R, Borkhardt A, Kosmehl H, Altmannsberger HM. Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas. Am J Pathol 1996;148:731-8.
28. Nagata Y, Abe M, Kobayashi K. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers. Cancer Res 1990;50:480-2.
29. Goodrow T, Reynolds S, Maronpot R, Anderson M. Activation of K-ras by codon 13 mutations in C57BL/6 × C3HF1 mouse tumors induced by exposure to 1,3-butadiene. Cancer Res 1990;50:4818-23.
30. Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D, Barbacid M. Direct mutagenesis of H-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogens in rats. Nature 1985;315:382-5.
31. Marion MJ, Froment O, Trepo C. Activation of Ki-ras gene by point mutation in human liver angiosarcoma associated with vinyl chloride exposure. Mol Carcinog 1991;4:450-4.